rs189297725

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_013275.6(ANKRD11):​c.6084C>T​(p.Pro2028Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00294 in 1,594,300 control chromosomes in the GnomAD database, including 121 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 70 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 51 hom. )

Consequence

ANKRD11
NM_013275.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -6.84

Publications

0 publications found
Variant links:
Genes affected
ANKRD11 (HGNC:21316): (ankyrin repeat domain containing 11) This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
ANKRD11 Gene-Disease associations (from GenCC):
  • KBG syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, Illumina, ClinGen
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-89280458-G-A is Benign according to our data. Variant chr16-89280458-G-A is described in ClinVar as Benign. ClinVar VariationId is 585416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.054 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD11NM_013275.6 linkc.6084C>T p.Pro2028Pro synonymous_variant Exon 9 of 13 ENST00000301030.10 NP_037407.4
ANKRD11NM_001256182.2 linkc.6084C>T p.Pro2028Pro synonymous_variant Exon 10 of 14 NP_001243111.1
ANKRD11NM_001256183.2 linkc.6084C>T p.Pro2028Pro synonymous_variant Exon 9 of 13 NP_001243112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD11ENST00000301030.10 linkc.6084C>T p.Pro2028Pro synonymous_variant Exon 9 of 13 5 NM_013275.6 ENSP00000301030.4

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2433
AN:
152232
Hom.:
70
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0559
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00536
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00362
AC:
788
AN:
217430
AF XY:
0.00289
show subpopulations
Gnomad AFR exome
AF:
0.0592
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000319
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00155
AC:
2242
AN:
1441950
Hom.:
51
Cov.:
34
AF XY:
0.00132
AC XY:
943
AN XY:
715140
show subpopulations
African (AFR)
AF:
0.0590
AC:
1936
AN:
32826
American (AMR)
AF:
0.00206
AC:
88
AN:
42808
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39112
South Asian (SAS)
AF:
0.0000588
AC:
5
AN:
85050
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51050
Middle Eastern (MID)
AF:
0.000371
AC:
2
AN:
5394
European-Non Finnish (NFE)
AF:
0.0000363
AC:
40
AN:
1101064
Other (OTH)
AF:
0.00289
AC:
171
AN:
59204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
148
297
445
594
742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0160
AC:
2440
AN:
152350
Hom.:
70
Cov.:
32
AF XY:
0.0158
AC XY:
1175
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0559
AC:
2326
AN:
41580
American (AMR)
AF:
0.00536
AC:
82
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68030
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
124
247
371
494
618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
2
Bravo
AF:
0.0180
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 05, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KBG syndrome Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.059
DANN
Benign
0.62
PhyloP100
-6.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189297725; hg19: chr16-89346866; API